PharmaCyte Biotech Inc Share Price Today: Live Updates & Key Insights

PharmaCyte Biotech Inc share price today is $0.6767, up -2.17%. The stock opened at $0.7246 against the previous close of $0.702, with an intraday high of $0.7246 and low of $0.6424.

PharmaCyte Biotech Inc Share Price Chart

PharmaCyte Biotech Inc

us-stock
To Invest in {{usstockname}}
us-stock

PharmaCyte Biotech Inc Share Price Performance

$0.6767 -0.0217(-2.17%) PMCB at 23 Mar 2026 02:47 PM Biotechnology
Lowest Today 0.6424
Highest Today 0.7246
Today’s Open 0.7246
Prev. Close 0.702
52 Week High 1.64
52 Week Low 0.63
Day’s Range: Low 0.6424 High 0.7246
52-Week Range: Low 0.63 High 1.64
1 day return -
1 Week return -5.48
1 month return -2.2
3 month return -23.24
6 month return -33.97
1 year return -55.98
3 year return -77.07
5 year return -77.69
10 year return -

PharmaCyte Biotech Inc Institutional Holdings

Citadel Advisors Llc 2.14

HRT FINANCIAL LLC 1.70

Geode Capital Management, LLC 1.15

Sabby Management LLC 0.93

Renaissance Technologies Corp 0.88

EQUITEC PROPRIETARY MARKETS, LLC 0.77

Vanguard Group Inc 0.70

Vanguard Institutional Extnd Mkt Idx Tr 0.51

Fidelity Extended Market Index 0.38

Fidelity Nasdaq Composite Index 0.26

Schonfeld Strategic Advisors LLC 0.24

TWO SIGMA SECURITIES, LLC 0.23

NT Ext Equity Mkt Idx Fd - L 0.20

Spartan Total Market Index Pool G 0.20

Northern Trust Corp 0.18

Fidelity Total Market Index 0.15

NT Ext Equity Mkt Idx Fd - NL 0.14

Fidelity Series Total Market Index 0.13

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.11

Jane Street Group LLC 0.11

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.08

Tower Research Capital LLC 0.05

Northern Trust Extended Eq Market Idx 0.04

BNYM Mellon SL Market Completion UC1 0.02

UBS Group AG 0.01

SIMPLEX TRADING, LLC 0.01

Northern Trust Wilshire 5000 0.01

NT US Market Cap Idx Fd - L 0.01

Bank of America Corp 0.01

State St US Ttl Mkt Indx NL Cl A 0.00

Advisor Group Holdings, Inc. 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Covestor Ltd 0.00

SSgA U.S. Total Market Index Strategy 0.00

Accredited Wealth Management, LLC 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

Aviso Financial Inc. 0.00

Sachetta LLC 0.00

PharmaCyte Biotech Inc Market Status

PharmaCyte Biotech Inc Fundamentals

Market Cap 7.37 M

PB Ratio 0.2068

PE Ratio 0.0

Enterprise Value -7.33 M

Total Assets 55.17 M

Volume 256611

PharmaCyte Biotech Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:0 0.0M, FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:null 0.0M, FY24:null 0.0M, FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:30656050 30.7M, FY24:333763 0.3M, FY23:-4315993 -4.3M, FY22:-4085799 -4.1M, FY21:-3554282 -3.6M

Quarterly Revenue Q1/2026:null 0.0M, Q4/2025:0 0.0M, Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M

Quarterly Profit Q1/2026:null 0.0M, Q4/2025:null 0.0M, Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M

Quarterly Net worth Q1/2026:746860 0.7M, Q4/2025:-7417975 -7.4M, Q3/2025:-8360096 -8.4M, Q2/2025:11749582 11.7M, Q1/2025:-3045000 -3.0M

About PharmaCyte Biotech Inc & investment objective

Company Information PharmaCyte Biotech, Inc., a biotechnology company, focused on developing and preparing to commercialize cellular therapies for cancer using live cell encapsulation technology in the United States. The company's cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer. It also develops CypCaps for pancreatic cancer and other solid cancerous tumors. It has a cooperation agreement with Iroquois Master Fund Ltd.; license agreements with SG Austria Pte. Ltd.; and Austrianova Singapore Pte. Ltd. to use the Cell-in-the-Box technology for cancer treatment. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Organisation Biotechnology

Employees 2

Industry Biotechnology

CEO Mr. Joshua N. Silverman

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

PharmaCyte Biotech Inc FAQs

What is the share price of PharmaCyte Biotech Inc today?

The current share price of PharmaCyte Biotech Inc is $0.6767.

Can I buy PharmaCyte Biotech Inc shares in India?

Yes, Indian investors can buy PharmaCyte Biotech Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy PharmaCyte Biotech Inc shares in India?

You can easily invest in PharmaCyte Biotech Inc shares from India by:

Can I buy fractional shares of PharmaCyte Biotech Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of PharmaCyte Biotech Inc?

PharmaCyte Biotech Inc has a market cap of $7.37 M.

In which sector does PharmaCyte Biotech Inc belong?

PharmaCyte Biotech Inc operates in the Biotechnology sector.

What documents are required to invest in PharmaCyte Biotech Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of PharmaCyte Biotech Inc?

The PE ratio of PharmaCyte Biotech Inc is N/A and the PB ratio is 0.21.